$CEAD
CEA Industries Inc. Stock $cead

$cead Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031980 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.461M	$5.063M	$3.706M
YoY Change	-52.2%	36.6%	126.74%
Cost Of Revenue	$1.310M	$4.466M	$2.959M
YoY Change	-47.7%	50.91%	166.9%
Gross Profit	$151.0K	$597.2K	$747.2K
YoY Change	-72.64%	-20.07%	42.07%
Gross Profit Margin	10.34%	11.8%	20.16%
Selling, General & Admin	$1.368M	$1.293M	$1.091M
YoY Change	-0.25%	18.48%	50.67%
% of Gross Profit	905.83%	216.47%	146.03%
Research & Development	$65.51K	$58.98K	$98.62K
YoY Change	-55.41%	-40.2%	16.81%
% of Gross Profit	43.38%	9.88%	13.2%
Depreciation & Amortization	$7.710K	$8.030K	$17.79K
YoY Change	-25.87%	-54.86%	-80.42%
% of Gross Profit	5.11%	1.34%	2.38%
Operating Expenses	$1.433M	$1.656M	$1.190M
YoY Change	-5.59%	39.22%	47.14%
Operating Profit	-$1.282M	-$1.059M	-$442.5K
YoY Change	32.7%	139.33%	56.56%
Interest Expense	$10.73K	$10.73K	-$1.300K
YoY Change	2338.64%	-925.38%	-110.64%
% of Operating Profit
Other Income/Expense, Net	$0.00	$17.08K	$35.93K
YoY Change	-100.0%	-52.45%	259.3%
Pretax Income	-$1.272M	-$1.042M	-$407.9K
YoY Change	216.4%	155.46%	50.83%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.272M	-$1.042M	-$407.9K
YoY Change	216.4%	155.46%	50.83%
Net Earnings / Revenue	-87.05%	-20.58%	-11.01%
Basic Earnings Per Share		-$0.13	-$1.69
Diluted Earnings Per Share	-$0.16	-$131.0K	-$257.6K
COMMON SHARES
Basic Shares Outstanding	7.954M shares	7.954M shares	1.584M shares
Diluted Shares Outstanding		7.954M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.64M	$21.08M	$2.284M
YoY Change	762.98%	823.15%	10.21%
Cash & Equivalents	$18.64M	$21.08M	$2.284M
Short-Term Investments
Other Short-Term Assets	$1.490M	$1.102M	$1.157M
YoY Change	16.97%	-4.75%	52.76%
Inventory	$348.4K	$614.6K	$480.4K
Prepaid Expenses
Receivables	$2.649K	$77.14K	$32.25K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$20.48M	$22.88M	$3.954M
YoY Change	413.09%	478.65%	14.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$68.51K	$76.22K	$293.3K
YoY Change	-11.42%	-74.01%	-48.46%
Goodwill
YoY Change
Intangibles	$1.830K	$1.830K
YoY Change	0.0%
Long-Term Investments
YoY Change
Other Assets	$14.75K	$14.75K	$24.18K
YoY Change	0.0%	-39.0%
Total Long-Term Assets	$548.0K	$581.8K	$955.4K
YoY Change	-57.55%	-39.11%	-20.88%
TOTAL ASSETS
Total Short-Term Assets	$20.48M	$22.88M	$3.954M
Total Long-Term Assets	$548.0K	$581.8K	$955.4K
Total Assets	$21.03M	$23.46M	$4.909M
YoY Change	298.07%	377.89%	5.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$311.2K	$1.360M	$864.6K
YoY Change	-49.49%	57.35%	23.89%
Accrued Expenses	$1.104M	$1.081M	$1.157M
YoY Change	20.91%	-6.52%	9.65%
Deferred Revenue	$4.339M	$4.435M
YoY Change	52.78%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.754M	$6.914M	$5.118M
YoY Change	30.59%	35.1%	-2.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$517.5K
YoY Change		-100.0%	-7.0%
Other Long-Term Liabilities	$376.9K	$405.3K	$37.08K
YoY Change		992.96%	-86.74%
Total Long-Term Liabilities	$376.9K	$405.3K	$554.6K
YoY Change	-22.49%	-26.92%	-33.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.754M	$6.914M	$5.118M
Total Long-Term Liabilities	$376.9K	$405.3K	$554.6K
Total Liabilities	$6.131M	$7.319M	$5.672M
YoY Change	25.31%	29.04%	-6.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.28M	-$33.01M
YoY Change	19.1%
Common Stock	$80.00	$80.00
YoY Change	400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.90M	$16.14M	-$763.4K
YoY Change
Total Liabilities & Shareholders Equity	$21.03M	$23.46M	$4.909M
YoY Change	298.07%	377.89%	5.43%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$1.272M	-$1.042M	-$407.9K
YoY Change	216.4%	155.46%	50.83%
Depreciation, Depletion And Amortization	$7.710K	$8.030K	$17.79K
YoY Change	-25.87%	-54.86%	-80.42%
Cash From Operating Activities	-$2.446M	$488.6K	-$619.5K
YoY Change	69.19%	-178.87%	-203.31%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$16.40K	$0.00
YoY Change	-100.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$16.40K	$0.00
YoY Change	-100.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	1.260M
YoY Change	-100.0%	-100.0%	127.41%
NET CHANGE
Cash From Operating Activities	-2.446M	488.6K	-619.5K
Cash From Investing Activities	0.000	-16.40K	0.000
Cash From Financing Activities	0.000	0.000	1.260M
Net Change In Cash	-2.446M	472.2K	640.4K
YoY Change	1868.64%	-26.27%	-44.32%
FREE CASH FLOW
Cash From Operating Activities	-$2.446M	$488.6K	-$619.5K
Capital Expenditures	$0.00	-$16.40K	$0.00
Free Cash Flow	-$2.446M	$505.0K	-$619.5K
YoY Change	75.67%	-181.52%	-202.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		usd
CY2022Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001482541
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Goodwill Goodwill		usd
CY2022Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment		usd
	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment		usd
CY2022Q3	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities		usd
CY2022Q3	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound		usd
CY2021Q3	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound		usd
	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound		usd
	CEAD	Stock Issued During Period Value Cashless Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants		usd
	CEAD	Common Stock Issued For Other Expense CommonStockIssuedForOtherExpense		usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
	CEAD	Increase Decrease In Operating Deposit IncreaseDecreaseInOperatingDeposit		usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock		usd
	CEAD	Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts		usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	22877453	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	CEAD	Adjustment Of Carrying Value Of Series B Preferred Stock To Redemption Value AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue		usd
	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock		usd
	CEAD	Subscription Receivable Series B Preferred Stock SubscriptionReceivableSeriesBPreferredStock		usd
	CEAD	Options Issued For Accrued Equity Compensation OptionsIssuedForAccruedEquityCompensation		usd
	CEAD	Accrued Series B Dividend Payable Settled In Shares Of Common Stock AccruedSeriesBDividendPayableSettledInSharesOfCommonStock		usd
	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound		usd
	CEAD	Cashless Exercise Or Prepaid Warrants CashlessExerciseOrPrepaidWarrants		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q3	CEAD	Remaining Performance Obligations Related To Engineering Only Paid Contracts RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts		usd
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercised Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations		shares
	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Expired ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expirations SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41266
	dei	Entity Registrant Name EntityRegistrantName	CEA INDUSTRIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3911608
	dei	Entity Address Address Line1 EntityAddressAddressLine1	385 South Pierce Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite C
	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
	dei	City Area Code CityAreaCode	(303)
	dei	Local Phone Number LocalPhoneNumber	993-5271
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7953974	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21083549	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2159608	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	275442	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	181942	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77143	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	179444	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	614623	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	378326	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1102138	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1273720	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3991098	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1830	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1830	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76224	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77346	usd
CY2021Q4	us-gaap	Goodwill Goodwill	631064	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	488960	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	565877	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	581761	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1290864	usd
CY2022Q3	us-gaap	Assets Assets	23459214	usd
CY2021Q4	us-gaap	Assets Assets	5281962	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2256111	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1345589	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4435481	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2839838	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	69560	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	83625	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37078	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37078	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115943	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100139	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6914173	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4406269	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405265	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	486226	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	405265	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	486226	usd
CY2022Q3	us-gaap	Liabilities Liabilities	7319438	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4892495	usd
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	3300	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3300	shares
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	3960000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3960000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7953974	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7953974	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9822391	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	80	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49146840	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25211017	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33007144	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28781566	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16139776	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23459214	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5281962	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5063079	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3706436	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10582470	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	4465888	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	2959264	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8828453	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8208368	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	597191	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	747172	usd
	us-gaap	Gross Profit GrossProfit	993938	usd
	us-gaap	Gross Profit GrossProfit	2374102	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	304600	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	224393	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	865305	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	569580	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58978	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	98623	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	254473	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	322807	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1292746	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	866699	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3684617	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2493930	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1656324	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1189715	usd
	us-gaap	Operating Expenses OperatingExpenses	5435459	usd
	us-gaap	Operating Expenses OperatingExpenses	3386317	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1059133	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-442543	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4441521	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1012215	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6358	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	35934	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	191358	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	79452	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10725	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1296	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24585	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3268	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17083	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34638	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	215943	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	76184	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1042050	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-407905	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4225578	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-936031	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1042050	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-407905	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4225578	usd
	us-gaap	Net Income Loss NetIncomeLoss	-936031	usd
CY2021Q3	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment	2262847	usd
	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment	2262847	usd
CY2021Q3	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	1447	usd
	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	35984	usd
	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	1447	usd
	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound	439999	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1042050	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2672199	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4701561	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3200325	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.02
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7953974	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1583511	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6804741	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1581142	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17126482	usd
CY2022Q3	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	49099	usd
CY2022Q3	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors	6245	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1042050	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16139776	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	208672	usd
	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors	29656	usd
	CEAD	Stock Issued During Period Value Common Shares Issued In Settlement Of Restricted Stock Units Issued To Directors StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors	24994	usd
	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors	17418	usd
	CEAD	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21711131	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1980000	usd
	CEAD	Adjustments To Additional Paid In Capital Dividends On Preferred Stock AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock	-35984	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4225578	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16139776	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1644642	usd
CY2021Q3	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	14545	usd
CY2021Q3	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors	14762	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	927721	usd
CY2021Q3	CEAD	Adjustments To Additional Paid In Capital Accrued Dividends AdjustmentsToAdditionalPaidInCapitalAccruedDividends	-1447	usd
CY2021Q3	CEAD	Adjustments To Additional Paid In Capital Redemption Value AdjustmentsToAdditionalPaidInCapitalRedemptionValue	-2262847	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-407905	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-3359813	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1333698	usd
	CEAD	Stock Issued During Period Value Common Shares To Be Issued In Settlement Of Legal Dispute StockIssuedDuringPeriodValueCommonSharesToBeIssuedInSettlementOfLegalDispute	67000	usd
	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	158315	usd
	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors	21174	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	927721	usd
	CEAD	Adjustments To Additional Paid In Capital Accrued Dividends AdjustmentsToAdditionalPaidInCapitalAccruedDividends	-1447	usd
	CEAD	Adjustments To Additional Paid In Capital Redemption Value AdjustmentsToAdditionalPaidInCapitalRedemptionValue	-2262847	usd
	us-gaap	Net Income Loss NetIncomeLoss	-936031	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-3359813	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4225578	usd
	us-gaap	Net Income Loss NetIncomeLoss	-936031	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24731	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54973	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	280739	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	51055	usd
	CEAD	Common Stock Issued For Other Expense CommonStockIssuedForOtherExpense	67000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	93500	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20975	usd
	us-gaap	Inventory Write Down InventoryWriteDown	-5332	usd
	us-gaap	Inventory Write Down InventoryWriteDown	-13764	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4489	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8042	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	76917	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	149597	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8801	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19740	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	230966	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	139481	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-171582	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	119296	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	910523	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-107604	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1595644	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-664663	usd
	CEAD	Increase Decrease In Operating Deposit IncreaseDecreaseInOperatingDeposit	-24183	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-65157	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-197085	usd
	CEAD	Increase Decrease In Deferred Compensation Accrued Equity Compensation IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation	-14065	usd
	CEAD	Increase Decrease In Deferred Compensation Accrued Equity Compensation IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation	108945	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-743108	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1761260	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30348	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15316	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2250	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28098	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13816	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	35984	usd
	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock	1980000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	1259874	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	514200	usd
	CEAD	Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts	21711131	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19695147	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1774074	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18923941	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1002	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2159608	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2284881	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21083549	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2283879	usd
	CEAD	Adjustment Of Carrying Value Of Series B Preferred Stock To Redemption Value AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue	2262847	usd
	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock	1980000	usd
	CEAD	Subscription Receivable Series B Preferred Stock SubscriptionReceivableSeriesBPreferredStock	1365000	usd
	CEAD	Options Issued For Accrued Equity Compensation OptionsIssuedForAccruedEquityCompensation	128434	usd
	CEAD	Accrued Series B Dividend Payable Settled In Shares Of Common Stock AccruedSeriesBDividendPayableSettledInSharesOfCommonStock	1447	usd
	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound	439999	usd
	CEAD	Cashless Exercise Or Prepaid Warrants CashlessExerciseOrPrepaidWarrants	2	usd
	us-gaap	Stock Issued1 StockIssued1	78938	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022.
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240125224	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240125224	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zB92L83SKUD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zDIeajcVKZJ7">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Cash Cash	21084000	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20834000	usd
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7881160	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	777888	shares
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5063079	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3706436	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9822391	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10582470	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4435481	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2839838	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	125731	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2318935	usd
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	283452	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3357068	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6832000	usd
CY2022Q3	CEAD	Remaining Performance Obligations Related To Partial Equipment Paid Contracts RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts	6832000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6832000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1050	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	311186	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	210944	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	186605	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	78531	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29307	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	266676	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zcPsxnxRjnre" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zFS1SsHEhNVa">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zdny8TzNGe55" title="Concentration risk percentage">53</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z3DCjVSL7aS5" title="Concentration risk percentage">24</span>% of the Company’s revenue for the three months ended September 30, 2022 and three customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zP7CEEbQUmuc" title="Concentration risk percentage">28</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zoAdHebGzgj7" title="Concentration risk percentage">25</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zkwsxccUru45" title="Concentration risk percentage">13</span>% of the Company’s revenue for the nine months ended September 30, 2022. Three customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMdDXOSlL5Jg" title="Concentration risk percentage">38</span>%, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zh4HNJLuRzZ5" title="Concentration risk percentage">23</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zu7FPE3wTnNk" title="Concentration risk percentage">11</span>% of the Company’s revenue for the three months ended September 30, 2021 and three customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zXGZh8AnjNs" title="Concentration risk percentage">25</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zDgbqaSFZT5b" title="Concentration risk percentage">12</span>%, and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zfLc5lWNV887" title="Concentration risk percentage">12</span>% of the Company’s revenue for the nine months ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z07kTL1tbrh3" title="Concentration risk percentage">54</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCnSvhJLS2s9" title="Concentration risk percentage">20</span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zJIgI3tas8ij" title="Concentration risk percentage">19</span>% of the Company’s accounts receivable as of September 30, 2022. Two customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTdQMHOARm8" title="Concentration risk percentage">68</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zMrB5lBacJPd" title="Concentration risk percentage">23</span>% of the Company’s accounts receivable as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	488960	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115943	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405265	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0363	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	80437	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	30767	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	124897	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	128643	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	132503	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	136473	usd
CY2022Q3	CEAD	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	11654	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	564937	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	43729	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	521208	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	389290	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	272199	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	194	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	196456	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	86047	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	91379	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	614623	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	378326	usd
	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	14986	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	13589	usd
CY2022Q3	CEAD	Prepaid Inventory Expenses PrepaidInventoryExpenses	760000	usd
CY2021Q4	CEAD	Prepaid Inventory Expenses PrepaidInventoryExpenses	1069000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	293389	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	289472	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	217165	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	212126	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76224	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77346	usd
	us-gaap	Depreciation Depreciation	24731	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1360380	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	616056	usd
CY2022Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	35229	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	27592	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	308576	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	322873	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	210944	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	186605	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	340982	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	192463	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2256111	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1345589	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1260000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1365000	usd
	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound	439999	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7953974	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7953974	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240125244	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240125244	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	169530	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	170382	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	227719	shares
CY2021Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	227719	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.59
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P33M
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	7566435	shares
	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted	7566435	shares
	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Granted ClassOfWarrantOrRightWeightedAverageExercisePriceGranted	4.89
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms	P53M
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted	177197	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	170382	shares
	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised	170382	shares
	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceExercised	0.01
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised	-177197	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2022Q3	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.14
	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P52M
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2022Q3	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P55M
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	25317000	usd
CY2022Q3	CEAD	Net Operating Loss Carry Forward Expected To Expire Amount NetOperatingLossCarryForwardExpectedToExpireAmount	11196000	usd
CY2022Q3	CEAD	Taxable Income Percentage TaxableIncomePercentage	0.80	pure
CY2022Q3	CEAD	Taxable Income Percentage TaxableIncomePercentage	0.80	pure

Files In Submission

Name	View Source	Status
0001493152-22-031980-index-headers.html	Edgar Link	pending
0001493152-22-031980-index.html	Edgar Link	pending
0001493152-22-031980.txt	Edgar Link	pending
0001493152-22-031980-xbrl.zip	Edgar Link	pending
cead-20220930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
cead-20220930_cal.xml	Edgar Link	unprocessable
cead-20220930_def.xml	Edgar Link	unprocessable
cead-20220930_lab.xml	Edgar Link	unprocessable
cead-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEAD
CEA Industries Inc. Stock $cead

2022 Q4 Form 10-Q Financial Statement

#000149315222031980 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD CEA Industries Inc. Stock $cead

2022 Q4 Form 10-Q Financial Statement

#000149315222031980 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD
CEA Industries Inc. Stock $cead